Immunohistochemical analysis of the T-cell receptor β-chain variable regions expressed by T lymphocytes infiltrating primary human melanoma

Laboratory Investigation

Volumn 78, Issue 5, 1998, Pages 619-627

  Clemente, Claudio ^a,c   Rao, Stefania ^a   Lupetti, Raffaella ^a   Tragni, Gabrina ^a   Pisarra, Patrizia ^a   Bersani, Ilaria ^a   Parmiani, Giorgio ^a   Mihm Jr , Martin C ^b   Sensi, Marialuisa ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ALBANY MEDICAL COLLEGE   (United States)

^c Riferimento Diagnostico Lesioni P   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CELL MOVEMENT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0031833460     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arden B, Clark SP, Kabelitz D, and Mak TW (1995). Human T-cell receptor variable gene segment families. Immunogenetics 42:455-501.
2. Bigler RD, Boselli CM, Foley B, and Vonderheid EC (1996). Failure of anti-T-cell receptor Vβ antibodies to consistently identify a malignant T-cell clone in Sezary syndrome. Am J Pathol 149:1477-1483.
3. Black MM, Opler SR, and Speer FD (1956). Structural representations of tumor-host relationship in gastric carcinoma. Surg Gynecol Obstet 102:599-603.
4. Boon T and van der Bruggen P (1996). Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-730.
5. Clark WH Jr, Elder DE, Guerry D IV, Braitmen LE, Trock BJ, Schultz D, Synnestvedt M, and Halpern AC (1989). Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81:1893-1904.
6. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, and Cascinelli N (1996). Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303-1310.
7. Davis M and Bjorkman P (1988). T-cell antigen receptor genes and T-cell recognition. Nature 334:395-397.
8. Dixon FJ and Moore RA (1953). Testicular tumors: A clinico-pathological study. Cancer 6:427-454.
9. Elston CW (1969). Cellular reaction to choriocarcinoma. J Pathol 97:261-268.
10. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, and Wiley DC (1996). Structure of the complex between human T-cell receptor, viral peptide, and HLA-A2. Nature 384:134-141.
11. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, and Wilson IA (1996). An ε/βT cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:217-219.
12. Hishii M, Andrews D, Boyle LA, Wong JT, Pandolfi F, van den Elsen P, and Kurnick JT (1997). In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc Natl Acad Sci U S A. 94:1378-1383.
13. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, and Terho R (1993). Tumor infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 29:69-75.
14. Lukes RJ and Butler JJ (1966). The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063-1081.
15. Mackensen A, Carcelain G, Viel S, Raynal MC, Michalaki H, Triebel F, Bosq J, and Hercend T (1994). Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 93:1397-1402.
16. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, and Hercend T (1993). Evidence for in situ amplification of cytotoxic T lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53:3569-3573.
17. Martin RF and Beckwith JB (1968). Lymphoid infiltrates in neuroblastoma: Their occurrence and prognostic significance. J Pediatr Surg 3:161-164.
18. Meggetto F, Al Saati T, Rubin B, and Delsol G (1994). Lack of restricted T-cell receptor β-chain variable region (Vβ) usage of reactive T lymphocytes in Hodgkin's disease. Br J Haematol 86:524-532.
19. Mihm MC Jr, Clemente C, and Cascinelli N (1996). Tumor infiltrating lymphocytes in lymph node melanoma metastases: A histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43-47.
20. Moore OS and Foote FW (1949). The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 2:635-642.
21. Ridley A and Cavanagh JB (1971). Lymphocytic infiltration in gliomas: Evidence of possible host resistance. Brain 94:117-124.
22. Salvi S, Segalla F, Rao S, Arienti F, Sartori M, Bratina G, Caronni E, Anichini A, Clemente C, Parmiani G, and Sensi M (1995). Overexpression of the T-cell receptor β-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res 55:3374-3379.
23. Sensi M and Parmiani G (1995). Analysis of TCR usage in human tumors: A new tool for assessing tumor-specific immune responses. Immunol Today 88:589-595.
24. Sensi M, Farina C, Maccalli C, Lupetti R, Nicolini G, Anichini A, Parmiani G, and Berd D (1997). Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine. J Clin Invest 4:710-717.
25. Sensi M, Salvi S, Castelli C, Maccalli C, Mazzochhi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, and Anichini A (1993). T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocytes (CTL) clones: Tumor-infiltrating lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2 restricted and melanocyte-lineage-specific CTL clone. J Exp Med 178: 1231-1246.
26. Strohal R, Marberger K, Pehamberger H, and Stingl G (1994). Immunohistological analysis of anti-melanoma host responses. Arch Dermatol Res 287:28-35.
27. thor Straten P, Becker J C, Seremet T, Brocker EB, and Zeuthen J (1996). Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest 97:279-284.